AI vs. radiologist: 400,000 women join landmark breast cancer screening trial

NCT ID NCT06934239

Recruiting now Diagnosis Sponsor: Jonsson Comprehensive Cancer Center Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This large trial compares standard mammogram reading by radiologists to reading with the help of an FDA-approved AI tool. The goal is to see if AI improves cancer detection and reduces unnecessary callbacks. About 400,000 adult women across six U.S. health systems will participate.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ARTIFICIAL INTELLIGENCE (AI) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ARTIFICIAL INTELLIGENCE (AI) BREAST CANCER SCREENING

Contacts and locations

Locations

Boston Medical Center
RECRUITING

Boston, Massachusetts, 02118, United States
University of California Los Angeles Health System
RECRUITING

Los Angeles, California, 90024, United States
University of California, San Diego
RECRUITING

San Diego, California, 92093, United States
University of Miami Health System
RECRUITING

Miami, Florida, 33136, United States
University of Washington Health System
RECRUITING

Seattle, Washington, 98195, United States
University of Wisconsin-Madison
RECRUITING

Madison, Wisconsin, 53706, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.